- Home
- QGEN vs SNEX Comparison
QGEN vs SNEX Comparison
Compare QGEN & SNEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | QGEN | SNEX |
|---|---|---|
| Founded | 1986 | 1924 |
| Country | Netherlands | United States |
| Employees | N/A | 5400 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.0B | 7.4B |
| IPO Year | 1998 | 1996 |
Fundamental Metrics
Financial Performance| Metric | QGEN | SNEX |
|---|---|---|
| Price | $48.15 | $57.30 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 16 | 3 |
| Target Price | $48.13 | ★ $133.28 |
| AVG Volume (30 Days) | ★ 2.3M | 958.9K |
| Earning Date | 11-03-2026 | 11-23-2026 |
| Dividend Yield | ★ 5.64% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 3.49 |
| Revenue | N/A | ★ $132,378,200,000.00 |
| Revenue This Year | $2.16 | N/A |
| Revenue Next Year | $5.06 | N/A |
| P/E Ratio | $24.01 | ★ $16.35 |
| Revenue Growth | N/A | ★ 32.53 |
| 52 Week Low | $32.53 | $55.71 |
| 52 Week High | $57.82 | $141.99 |
Technical Indicators
Market Signals| Indicator | QGEN | SNEX |
|---|---|---|
| Relative Strength Index (RSI) | 64.77 | 30.46 |
| Support Level | $46.72 | N/A |
| Resistance Level | $49.86 | $71.09 |
| Average True Range (ATR) | 1.28 | 2.16 |
| MACD | 0.30 | -0.38 |
| Stochastic Oscillator | 62.06 | 12.25 |
Price Performance
Historical ComparisonAbout QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables, with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by Europe, the Middle East, and Africa (33%) and Asia-Pacific (15%).
About SNEX StoneX Group Inc.
StoneX Group Inc is a brokerage and financial services firm. Its service offerings are execution, OTC / Market-Making, advisory services, payment solutions, market intelligence, Physical Trading and clearing services. The firm operates in four segments: Commercial, Institutional, Self-Directed/Retail, and Payments. Its customers include governmental and nongovernmental organizations, commercial banks, brokers, institutional investors, and investment banks. The company operates in the United States, South America, Europe, the Middle East and Asia, and other countries, out of which the majority of revenue is generated from the Middle East and Asia Region.